8:00 am Check-In & Coffee

8:50 am Chair’s Opening Remarks

Harnessing Insights from Cell & Gene Therapy Pioneers to Optimize Medical Affairs Strategies

9:00 am Industry Leader’s Fireside Chat: Overcoming Current & Future Challenges in Cell & Gene Medical Affairs

• Ike Ogbaa Former Vice President, Global Head of Medical Affairs, bluebird bio
• Alexander Maurer Executive Director, WW Cell Therapy Franchise Medical Lead, Bristol Myers Squibb
• Kent Christopherson Executive Director & Head of Global Medical Affairs, Orchard Therapeutics

10:00 am Morning Break & Speed Networking

Unveiling the Impact of Medical Affairs in Early-Stage Development

11:00 am Advocating for Early Integration of Medical Affairs Teams in the Pre-Launch Phase

• AiThi Sprinkle Associate Director, Medical Science Liaison, Vor Bio

11:30 am The Evolution of Medical Affairs in the Era of Cell & Gene Therapy

• Warren Rizzo Scientific & Medical Affairs Consultant, ImmPACT Bio

12:00 pm Panel Discussion: Starting with the End in Mind – Investing in Medical Affairs Early to Improve Long-Term Success

• Preeti Joshi Senior Director, Medical Affairs, BlueRock Therapeutics
• Ike Ogbaa Former Vice President, Global Head of Medical Affairs, bluebird bio
• Angela Tom Senior Director, Medical Affairs, Editas Medicine
• AiThi Sprinkle Associate Director, Medical Science Liaison, Vor Bio

12:45 pm Lunch Break & Networking

Establishing & Maintaining a Treatment Network for a Cell & Gene Product

1:45 pm Medical Affairs Global Role in Establishing Efficient & Standardized Treatment Center Qualification

• Katie Snell Associate Director, Global Medical Affairs, Orchard Therapeutics

2:15 pm Roundtable Discussion: Preparing Treatment Centers to Receive & Administer Cell & Gene Therapies

3:15 pm Afternoon Break & Networking

Developing a Bespoke Medical Affairs Strategy to Ensure Success in a Complex Cell & Gene Landscape

3:45 pm The Eye of the Tiger: A Focused Look into Autologous vs Allogeneic CARTs to Sharpen Medical Affairs Strategies

• Tonia Nesheiwat Vice President, Medical Affairs & Project Leadership, Caribou Biosciences

4:15 pm Tailoring a Medical Strategy for Success in a Multi-CGT Landscape

• Eileen Sawyer Former Senior Vice President, Clinical & Medical Affairs, Independent Expert

4:45 pm Chair’s Closing Remarks

4:50 pm End of Conference Day One